1-(Chloromethyl)Cyclohexanecarbonitrile → Pyrimidoindolone, 25e
반응식
[CH3:1][O:2][CH2:3][C@@H:4]1[CH2:8][CH2:7][CH2:6][N:5]1[S:9]([C:12]1[CH:13]=[C:14]2[C:18](=[CH:19][CH:20]=1)[NH:17][C:16](=O)[C:15]12[O:26]CCCO1)(=[O:11])=[O:10].Cl[CH2:28][C:29]1([C:35]#[N:36])[CH2:34][CH2:33][CH2:32][CH2:31][CH2:30]1>>[CH3:1][O:2][CH2:3][C@@H:4]1[CH2:8][CH2:7][CH2:6][N:5]1[S:9]([C:12]1[CH:20]=[CH:19][C:18]2[N:17]3[CH2:28][C:29]4([CH2:34][CH2:33][CH2:32][CH2:31][CH2:30]4)[CH2:35][N:36]=[C:16]3[C:15](=[O:26])[C:14]=2[CH:13]=1)(=[O:11])=[O:10]참가 물질
3
실험 절차
The title compound was prepared as a yellow foam from 5′-{[(2S)-2-(methoxymethyl)pyrrolidin-1-yl]sulfonyl}spiro[1,3-dioxane-2,3′-indol]-2′(1′H)-one and 1-chloromethyl-cyclohexanecarbonitrile (Syn. Comm. 20(12) 1757, 1990) using a procedure similar to that of steps 3-5 of Example 12. NMR (400 Mz, DMSO-d6): consistent. MS: (ES−) m/z 430 [M−H].
출처 및 근거
- ORD 기록
- ord-84fe78f842b845768f0c5fa40219ab02
- 출처 데이터셋
- uspto-grants-2007_08